SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14C - Other definitive information statements:
SEC Accession No. 0001662252-18-000046
Filing Date
2018-03-15
Accepted
2018-03-15 16:44:23
Documents
1
Period of Report
2018-02-28
Effectiveness Date
2018-03-15

Document Format Files

Seq Description Document Type Size
1 DEF 14C rchadef14c.htm DEF 14C 549225
  Complete submission text file 0001662252-18-000046.txt   550326
Mailing Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212
Business Address 9595 WILSHIRE BLVD., SUITE 900 BEVERLY HILLS CA 90212 (424) 230-7001
Rich Pharmaceuticals, Inc. (Filer) CIK: 0001504389 (see all company filings)

IRS No.: 463259117 | Fiscal Year End: 0331
Type: DEF 14C | Act: 34 | File No.: 000-54767 | Film No.: 18693026
SIC: 2834 Pharmaceutical Preparations